Digoxin

CAS : 20830-75-5

Ref. 3D-OD01513

Informations sur le produit

• Nom: Digoxin
• Synonymes: 12b-Hydroxydigitoxin Lanicor, (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide, (3beta,5beta,8xi,9xi,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide, (3β,5β,12β)-3-[(O-2,6-Dideoxy-β-<span class="text-smallcaps">D</smallcap>-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-<smallcap>D</smallcap>-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide, 12β-Hydroxydigitoxin, Card-20(22)-enolide, 3-[(O-2,6-dideoxy-β-<span class="text-smallcaps">D</smallcap>-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-<smallcap>D</smallcap>-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-, Card-20(22)-enolide, 3-[(O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-, Cardigox, Cardiogoxin, Cardioxin, Cardixin, Cardoxin, Chloroformic digitalin, Coragoxine, Cordioxil, Davoxin, Digacin, Digicor, Digitek, Digitoxin, 12β-hydroxy-, Digomal, Digon, Digosin, Digoxin (FDA), Digoxin Nativelle, Digoxina, Digoxine, Dilanacin, Dixina, Dokim, Dynamos, Eudigox, Fargoxin, Grexin, Homolle's digitalin, Lanacordin, Lanacrist, Lanicor, Lanikor, Lanocardin, Lanorale, Lanoxicaps, Lanoxin, Lanoxin PG, Lenoxicaps, Lenoxin, Longdigox, Mapluxin, Natigoxin, NeoDioxanin, Novodigal-Amp., Nsc 95100, Purgoxin, Rougoxin, Stillacor, Toloxin, Vanoxin
• CAS: 20830-75-5

Description

Digoxin and its derivatives are the most widely used as cardiac glycosides. Digoxin is isolated from the foxglove plant, Digitalis lanata, and has pharmacokinetic properties that are intermediate between digitoxin and the short acting strophanthus glycosides. Digoxin is regarded as the drug of choice for the treatment of congestive heart failure as its main assets are the rapid onset of action, good absorption ratio and the medium half-life which makes toxic reactions easier to manage (Albrecht, 1999).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 780.94 g/mol
• Formule: C₄₁H₆₄O₁₄
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder